Blood Microbiota as a Potential Noninvasive Diagnostic Biomarker for Liver Fibrosis in Severely Obese Patients: Choose Carefully

Hepatology - United States
doi 10.1002/hep.28987
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B

PLoS ONE
Multidisciplinary
2015English

Is Endocan a Novel Potential Biomarker of Liver Steatosis and Fibrosis?

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2019English

Anti-Mda5 Antibody as a Potential Diagnostic and Prognostic Biomarker in Patients With Dermatomyositis

Oncotarget
Oncology
2017English

Phosphorylated Alpha-Synuclein in Red Blood Cells as a Potential Diagnostic Biomarker for Multiple System Atrophy: A Pilot Study

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2020English

Cystatin B as a Potential Diagnostic Biomarker in Ovarian Clear Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Limitations of Noninvasive Tests for Assessment of Liver Fibrosis

JHEP Reports
2020English

A Novel, Noninvasive, Predictive Epilepsy Biomarker With Clinical Potential

Journal of Neuroscience
Neuroscience
2014English

Determination of Liver Fibrosis Stages in Egyptian Chronic Hepatitis B Patients by a Noninvasive Tool

Turkish Journal of Medical Sciences
Medicine
2019English

FABP1 as a Novel Potential Biomarker for Predicting Mortality in Acetaminophen-Induced Acute Liver Failure

Hepatology
MedicineHepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy